Carol Bye is Vice President, Global Head of Pharmaceutical Sciences Quality Assurance, for Pfizer. Her current role is head of Quality Assurance for Pfizer’s global development and Investigational Medicinal Product portfolio, with quality accountability for the development and supply of new large and small molecule products to Pfizer clinical trials. Carol has worked within various process and technology development, engineering, manufacturing and quality assurance roles for 21 years, first with AstraZeneca then joining Pfizer in 1999. Whilst at Pfizer, Carol has held various technical and manufacturing operations management roles, moving to Quality Assurance in 2007, where she has assumed quality leadership roles of increasing responsibility, and was assigned to her current role in 2010. A native of Ireland, Carol received her honours undergraduate degree in chemical engineering in University College Dublin. Carol is a Fellow of the Institute of Chemical Engineers in the UK.